Is Brazil about to legislate on device reprocessing?
This article was originally published in Clinica
Executive Summary
The Brazilian healthcare surveillance agency Anvisa may be about to legislate on new measures to control the reprocessing of medical devices. The agency last week said that it was "studying the results of the consultation and consolidating them into the new regulations". However, four months after hosting an open "audience" to debate the draft legislation, as part of a lengthy consultation launched in March 2004, the agency has now published a full transcript of this debate.
You may also be interested in...
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.